13F

STIM NEURONETICS INC

2026Q1 · CUSIP 64131A105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
98
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
48
Δ whales
-1
Inst. holding value
$60M
New positions
28
Closed positions
25
Price momentum (1Q)
Put / Call
2/2

Breadth history (34 quarters)

2018Q3: Δ+9 · h=75 2018Q4: Δ-12 · h=63 2019Q1: Δ+4 · h=67 2019Q2: Δ-7 · h=60 2019Q3: Δ+6 · h=66 2019Q4: Δ+3 · h=69 2020Q1: Δ-9 · h=60 2020Q2: Δ-4 · h=56 2020Q3: Δ+0 · h=56 2020Q4: Δ+6 · h=62 2021Q1: Δ+22 · h=84 2021Q2: Δ+21 · h=105 2021Q3: Δ-8 · h=97 2021Q4: Δ-15 · h=82 2022Q1: Δ+1 · h=83 2022Q2: Δ-5 · h=78 2022Q3: Δ-1 · h=77 2022Q4: Δ+6 · h=83 2023Q1: Δ-8 · h=75 2023Q2: Δ-5 · h=70 2023Q3: Δ-13 · h=57 2023Q4: Δ+10 · h=67 2024Q1: Δ+0 · h=67 2024Q2: Δ+0 · h=67 2024Q3: Δ-18 · h=49 2024Q4: Δ-3 · h=46 2025Q1: Δ+57 · h=103 2025Q2: Δ-12 · h=91 2025Q3: Δ+10 · h=101 2025Q4: Δ-6 · h=95 2026Q1: Δ+3 · h=98 2018Q3: holders=75 2018Q4: holders=63 2019Q1: holders=67 2019Q2: holders=60 2019Q3: holders=66 2019Q4: holders=69 2020Q1: holders=60 2020Q2: holders=56 2020Q3: holders=56 2020Q4: holders=62 2021Q1: holders=84 2021Q2: holders=105 2021Q3: holders=97 2021Q4: holders=82 2022Q1: holders=83 2022Q2: holders=78 2022Q3: holders=77 2022Q4: holders=83 2023Q1: holders=75 2023Q2: holders=70 2023Q3: holders=57 2023Q4: holders=67 2024Q1: holders=67 2024Q2: holders=67 2024Q3: holders=49 2024Q4: holders=46 2025Q1: holders=103 2025Q2: holders=91 2025Q3: holders=101 2025Q4: holders=95 2026Q1: holders=98 -57 -28.5 +0 +28.5 +57 4176111 18Q319Q220Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 2%
2021Q2 Top 13% -41.2% -65.5%
2021Q1 Top 16% -33.3% -60.8%

Options Sentiment

Put holders
2
QoQ: -1
Call holders
2
QoQ: -3

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.54
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+69.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $16M 2022-09-30: $16M 2022-12-31: $18M 2023-03-31: $16M 2023-06-30: $18M 2023-09-30: $18M 2023-12-31: $20M 2024-03-31: $17M 2024-06-30: $16M 2024-09-30: $19M 2024-12-31: $22M 2025-03-31: $32M 2025-06-30: $38M 2025-09-30: $37M 2025-12-31: $42M 2026-03-31: $34M 2025-03-31: EPS -0.21 2025-06-30: EPS -0.15 2025-09-30: EPS -0.13 2025-12-31: EPS -0.10 2026-03-31: EPS -0.16 0M 21M 42M $M -0.23 -0.12 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)